Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

NCT00260039 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

680

Enrollment

INDUSTRY

Sponsor class

Conditions

HPV
Cervical Cancer
Premalignancy Anogenital Warts

Interventions

BIOLOGICAL: Comparator: Gardasil
BIOLOGICAL: Comparator: octavalent HPV Vaccine - dose formulation 1
BIOLOGICAL: Comparator: octavalent HPV Vaccine - dose formulation 2
BIOLOGICAL: Comparator: octavalent HPV Vaccine - dose formulation 3

Sponsor

Merck Sharp & Dohme LLC